|
|
Boehringer Ingelheim Announces Pivotal Phase III Data Showing Linagliptin ... - PR Newswire (press release) |
|
|
|
PR Newswire (press release)Notably, in these trials in type 2 diabetes patients with mild and moderate renal impairment, linagliptin blood plasma levels were comparable to those seen ...Boehringer's First Diabetes Pill Lowered Blood Sugar in Study BusinessWeekBoehringer Ingelheim Announces Results of Phase III Data Showing That ... |
|
|
|
|
|
<< Start < Prev 1481 1482 1483 1484 1485 1486 1487 1488 1489 1490 Next > End >>
|
|
Page 1489 of 2630 |